Curzion Pharmaceuticals Inc
acquired by Horizon TherapeuticsSan Diego, US · Founded 2019 · Delaware corporation · 2 known investors
Acquired by Horizon Therapeutics in 2020.
Founders & leadership
MG
Mike GreyExecutive
SD
Susan DubeExecutive
Board
KR
Kyle RasbachBoard director
NO
JK
Johan KordelBoard director
EM
Investors · 2
Reported raises · per SEC filings
Form D private placements$3.5M disclosed across 1 round · 2019
▶$3.5MraisedJul 2019 · 8 investors · PharmaceuticalsRule 506(b)
▶$3.5MraisedJul 2019 · 8 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Kyle RasbachDirector
- Niall O'DonnellDirector
- Johan KordelDirector
- Mike GreyExecutive Officer, Director
- Ed MathersDirector
- Susan DubeExecutive Officer
- Offering amount
- $3.5M
- Amount sold
- $3.5M
- First sale
- Mar 2019
- Incorporated
- Corporation, Delaware, 2019
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- What does Curzion Pharmaceuticals Inc do?
- Acquired by Horizon Therapeutics in 2020.
- Who are Curzion Pharmaceuticals Inc's investors?
- Curzion Pharmaceuticals Inc's investors include New Enterprise Associates (NEA), RiverVest Venture Partners.
- How much funding has Curzion Pharmaceuticals Inc raised?
- Curzion Pharmaceuticals Inc has disclosed $3.5M raised across 1 round.
- Who acquired Curzion Pharmaceuticals Inc?
- Curzion Pharmaceuticals Inc was acquired by Horizon Therapeutics.
- Where is Curzion Pharmaceuticals Inc headquartered?
- Curzion Pharmaceuticals Inc is headquartered in San Diego, US.